Mozz - nice write up. I do wonder if some of the stats on founder-leds have been hugely skewed by the FAANGs, Tesla etc. Nevertheless, I like the Board and CEOs to have skin in the game. Sure, there are risks, and as PissedSister and LuckDill have said above, PR has exhibited a few of these. I hope he lets go and acts like a Chair rather than sticking his nose in the new CEO's business.
I think the bit of the write up I like best is the other avenues that PAR is looking at. It's some of the stuff that will keep me interested on the long road to OA of the knee. MPS is one of these. I really like that one. The others are all building blocks for a more diversified company, although still iPPS. The bit I want to hear more about is the other drugs PR said they were working on repurposing. That'll be fascinating. Gotta be careful not to overstretch whilewehaven't got revenue - but can't wait to hear.
I'm surprised the SP is where it is post-Phase III approval. I'm sure the manipulators, who I guess pay some on these threads (maybe PissedSister?), have a lot to do with it - but certainly provides the opportunity to add to holdings if you've done your due diligence.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)